Cargando…

Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation

INTRODUCTION: There exists variability in the administration of in‐patient sotalol therapy for symptomatic atrial fibrillation (AF). The impact of this variability on patient in‐hospital and 30‐day posthospitalization costs and outcomes is not known. Also, the cost impact of intravenous sotalol, whi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varela, Daniel L., Burnham, Tyson S., T. May, Heidi, L. Bair, Tami, Steinberg, Benjamin A., B. Muhlestein, Joseph, L. Anderson, Jeffrey, U. Knowlton, Kirk, Jared Bunch, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305518/ https://www.ncbi.nlm.nih.gov/pubmed/34953091 http://dx.doi.org/10.1111/jce.15342

Ejemplares similares

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
por: Bunch, Thomas Jared, et al.
Publicado: (2022)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
por: Cutler, Michael J., et al.
Publicado: (2022)

Mortality and ventricular arrhythmias in patients with atrial fibrillation on sotalol
por: Lenhoff, H, et al.
Publicado: (2023)

Improving CHA(2)DS(2)-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation
por: Graves, Kevin G, et al.
Publicado: (2018)

Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis
por: Muhlestein, Joseph B., et al.
Publicado: (2022)

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2023)

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation
por: Lenhoff, Hanna, et al.
Publicado: (2021)

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

A COMPARISON OF CARDIOVASCULAR OUTCOMES AMONG SARS-COV-2 POSITIVE PATIENTS, SARS-COV-2 NEGATIVE PATIENTS, AND A HISTORICAL COHORT
por: May, Heidi Thomas, et al.
Publicado: (2023)

Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry
por: Horne, Benjamin D, et al.
Publicado: (2022)

Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation
por: Decloedt, Annelies, et al.
Publicado: (2018)

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population
por: Muhlestein, Joseph B., et al.
Publicado: (2020)

Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial
por: Horne, Benjamin D., et al.
Publicado: (2021)

Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial
por: Horne, Benjamin D., et al.
Publicado: (2023)

Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

Comparative clinical outcomes of dronedarone and sotalol in Asian patients with atrial fibrillation: a nationwide cohort study
por: Lee, So-Ryoung, et al.
Publicado: (2020)

Outpatient Initiation of Sotalol in Patients with Atrial Fibrillation: Utility of Cardiac Implantable Electronic Devices for Therapy Monitoring
por: Mascarenhas, Daniel A. N., et al.
Publicado: (2021)

Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta‐analysis
por: Singh, Jagmeet P., et al.
Publicado: (2023)

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications
por: Bunch, T. Jared, et al.
Publicado: (2016)

Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
por: Wharton, John Marcus, et al.
Publicado: (2022)

Intravenous sotalol for conversion of atrial flutter in infants
por: Aljohani, Othman A., et al.
Publicado: (2018)

IMPACT OF THE COVID PANDEMIC ON DEPRESSIVE SYMPTOMS AND SEVERITY
por: May, Heidi Thomas, et al.
Publicado: (2023)

Correction to: Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
Publicado: (2022)

Impact of Catheter Ablation on Stroke, Cognitive Decline and Dementia
por: Burnham, Tyson S, et al.
Publicado: (2021)

Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes
por: Bunch, T Jared, et al.
Publicado: (2019)

ROUTINE PERIODIC FASTING IS ASSOCIATED WITH A LOWER RISK OF INPATIENT HOSPITALIZATION FOR THE PRIMARY DIAGNOSIS OF HEART FAILURE FOLLOWING COVID-19 DIAGNOSIS
por: Horne, Benjamin Davies, et al.
Publicado: (2023)

Outpatient intravenous sotalol load to replace 3-day admission oral sotalol load
por: Von Bergen, Nicholas H., et al.
Publicado: (2019)

Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study
por: Meng, Zhaowei, et al.
Publicado: (2015)

New-Onset Atrial Fibrillation in the Critically Ill*
por: Moss, Travis J., et al.
Publicado: (2017)

Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy
por: Chen, Chris, et al.
Publicado: (2023)

A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL(3)+IDL])
por: May, Heidi T, et al.
Publicado: (2013)

Clearance of Sotalol on continuous venovenous haemofiltration
por: Roberts, H, et al.
Publicado: (2005)

Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis
por: Aerra, V, et al.
Publicado: (2006)

Repeated Measurement of the Intermountain Risk Score Enhances Prognostication for Mortality
por: Horne, Benjamin D., et al.
Publicado: (2013)

This is Your Brain, and This is Your Brain on Atrial Fibrillation: The Roles of Cardiac Malperfusion Events and Vascular Dysfunction in Cognitive Impairment
por: Zenger, Brian, et al.
Publicado: (2023)

Atrial fibrillation ablation performed in the developing world: A description of the first atrial fibrillation ablation performed in Cambodia
por: Sundaram, Sri, et al.
Publicado: (2015)

Nearly Fatal Torsade de Pointes with Sotalol
por: Strohmer, Bernhard, et al.
Publicado: (2003)

Use of intravenous sotalol in newborns with supraventricular tachycardia
por: Kim, Hannah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kn66alc5gu14qto49hc8l2dn14